EUVIMEDEUVIMED entdecken
Crossref

IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice

Jing Wang, Tingting Wu, Yanan Zhao, Lingyan Mao, Jing Ding, Xin Wang

Molecular Neurobiology · 2024

DOI: 10.1007/s12035-024-04203-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2024. Verfasst von Jing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Interleukin-17, src-Family Kinases, Signal Transduction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is an important pathogenic driving force in the genesis and development of epilepsy. The latest researches demonstrated that IL-17A mediated blood-brain barrier (BBB) dysfunction through disruption of tight junction protein expression. To investigate whether IL-17A is involved in BBB disruption after acute seizure attack, the pilocarpine model was established with C57BL/6 J (wild type, WT) and IL-17R-deficient mice in vivo and with primary cultured rat brain microvascular endothelial cells in vitro. The mortality rate and brain water content were evaluated at 24 h after status epilepticus, and IL-17A concentration, endothelial tight junction, adherens junction proteins, and albumin leakage were assessed at 0 h, 4 h, 12 h, and 24 h after status epilepticus (SE). IL-17R-deficient mice showed lessen severity of epilepsy than WT mice, accompanied by less albumin leakage, reduced brain water content, decreased IL-17A, and upregulated expression of target proteins (ZO-1, Occludin and VE-cadherin). IL-17R knockout abrogated abnormal upregulation of Src kinase and phosphorylated Src kinase in the setting of SE, and Src kinase inhibitor PP1 abrogated IL-17A-induced SE related endothelial injury in vitro. In conclusion, IL-17A inhibition might be a promising therapeutic option to attenuate endothelial cell injury and further BBB disruption by reducing Src kinase activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierInterleukin-17src-Family KinasesSignal TransductionMice, Inbred C57BLEpilepsyEndothelial CellsMice, KnockoutReceptors, Interleukin-17AnimalsMaleStatus EpilepticusTight JunctionsMicePilocarpine

Stichwörter der Autor:innen

Adherens junctionBlood–brain barrierEpilepsyIL-17ASrc kinaseTight junction

Substanzen

Interleukin-17src-Family KinasesReceptors, Interleukin-17Pilocarpine

Autor:innen und Institutionen

  • Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
  • Department of Neurology, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Neurology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. ding.jing@zs-hospital.sh.cn.
  • CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, China. ding.jing@zs-hospital.sh.cn.
  • CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, China.

Zitieren

APA

Wang, J., Wu, T., Zhao, Y., Mao, L., Ding, J., & Wang, X. (2024). IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04203-7

Vancouver

Wang J, Wu T, Zhao Y, Mao L, Ding J, Wang X. IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice. Molecular Neurobiology. 2024. doi:10.1007/s12035-024-04203-7

BibTeX
@article{Wang2024,
  author = {Wang, Jing and Wu, Tingting and Zhao, Yanan and Mao, Lingyan and Ding, Jing and Wang, Xin},
  title = {IL-17A Aggravated Blood–Brain Barrier Disruption via Activating Src Signaling in Epilepsy Mice},
  journal = {Molecular Neurobiology},
  year = {2024},
  doi = {10.1007/s12035-024-04203-7}
}
Kostenlos starten →